Table 1 Patient Characteristics and clinical variables
Patients | ||
|---|---|---|
N | % | |
Age (years) | ||
Median (range) | 47 (21-78) | |
Menopausal stastus | ||
Premenopausal | 81 | 55.1 |
Postmenopausal | 66 | 44.9 |
Primary cancer site | ||
Colon & Rectum | 72 | 49.0 |
Rectum | 18 | 25.0 |
Colon | 54 | 75.0 |
Stomach | 60 | 40.8 |
Breast | 12 | 8.2 |
Biliary Duct | 2 | 1.4 |
Liver | 1 | 0.7 |
Timing of metastasis to ovary | ||
Metachronous | 92 | 62.6 |
Synchronous | 55 | 37.4 |
Combined with metastases outside ovaries | ||
No | 107 | 72.8 |
Yes | 40 | 27.2 |
Ovary involvement | ||
Bilaterial | 97 | 66 |
Unilaterial | 50 | 34 |
Locally invasion | ||
No | 104 | 70.7 |
Yes | 43 | 29.3 |
Ascites | ||
≥1000 mL | 39 | 26.5 |
<1000 mL | 108 | 73.5 |
Size of ovarian metastases | ||
Median (range) | 9.0 (2.5-23cm) | |
≤5 cm | 45 | 30.6 |
5-10 cm | 48 | 32.7 |
>10 cm | 54 | 36.7 |
Histologic type | ||
Adenocarcinoma | 91 | 61.9 |
Mucinous carcinoma | 17 | 11.6 |
Signet ring cell carcinoma | 39 | 26.5 |
Pre-operation serum CA125 | ||
Normal | 42 | 28.6 |
Elevated | 105 | 71.4 |
Pre-operation serum CEA | ||
Normal | 96 | 65.3 |
Elevated | 51 | 34.7 |
Pre-operation serum LDH | ||
Normal | 117 | 79.6 |
Elevated | 28 | 6.0 |
Unknown | 2 | 1.4 |